Needham, Massachusetts
United States
57
2026-06-11
The entities that hold a legal rights for patent applications filed by inventor Akinc Akin:
Akin Akinc from Needham, US has applied for patents for these inventions. The list has both pending applications and granted patents:
CORONAVIRUS IRNA COMPOSITIONS AND METHODS OF USE THEREOF
#2 | 2026-01-15FACTOR XII (HAGEMAN FACTOR) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), AND KININOGEN 1 (KNG1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
#3 | 2026-01-01SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#4 | 2025-05-29COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE
#5 | 2024-10-17BETA-CATENIN (CTNNB1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#6 | 2024-08-01BETA-CATENIN (CTNNB1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#7 | 2024-03-21COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE
#8 | 2024-03-07FACTOR XII (HAGEMAN FACTOR) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), AND KININOGEN 1 (KNG1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
#9 | 2023-09-14RNAi COMPOSITIONS AND METHODS OF USE THEREOF FOR DELIVERY BY INHALATION
#10 | 2023-06-22TRANSMEMBRANE SERINE PROTEASE 2 (TMPRSS2) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
#11 | 2023-05-25METHODS AND COMPOSITIONS FOR TREATING A BLEEDING EVENT IN A SUBJECT HAVING HEMOPHILIA
#12 | 2023-05-04ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#13 | 2022-04-28CORONAVIRUS IRNA COMPOSITIONS AND METHODS OF USE THEREOF
#14 | 2022-03-17SERPINC1 iRNA Compositions and Methods of Use Thereof
#15 | 2022-01-20METHODS AND COMPOSITIONS FOR TREATING A SERPINC1-ASSOCIATED DISORDER
#16 | 2021-12-30COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE
#17 | 2021-12-28Coronavirus iRNA compositions and methods of use thereof
#18 | 2021-08-12Factor XII (Hageman Factor) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), and Kininogen 1 (KNG1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#19 | 2020-10-08Compositions and Methods for Inhibiting Expression of the PCSK9 Gene
#20 | 2020-07-09SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#21 | 2020-05-28METHODS AND COMPOSITIONS FOR TREATING A BLEEDING EVENT IN A SUBJECT HAVING HEMOPHILIA
#22 | 2020-04-30Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof
#23 | 2019-05-23METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA
#24 | 2018-08-02Compositions and methods for inhibiting expression of the PCSK9 gene
#25 | 2018-04-12Factor XII (Hageman Factor) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), and Kininogen 1 (KNG1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#26 | 2017-06-08Methods and compositions for treating a Serpinc1-associated disorder
#27 | 2017-01-05LIPID FORMULATED DSRNA TARGETING THE PCSK9 GENE
#28 | 2016-12-01Compositions and methods for inhibiting expression of the PCSK9 gene
#29 | 2016-09-08SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#30 | 2016-06-30Compositions and methods for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression
#31 | 2016-01-28Methods for increasing efficacy of lipid formulated siRNA
#32 | 2016-01-21COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR VII GENE
#33 | 2016-01-21Serpinc1 iRNA compositions and methods of use thereof
#34 | 2014-11-27Compositions and methods for inhibiting expression of the PCSK9 gene
#35 | 2014-11-20Compositions and methods for inhibiting expression of factor VII gene
#36 | 2014-09-25Lipid Formulated Compositions and Methods for Inhibiting Expression of Eg5 And VEGF Genes
#37 | 2014-05-08Compositions and method for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression
#38 | 2014-05-01LIPID FORMULATED DSRNA TARGETING THE PCSK9 GENE
#39 | 2013-12-12Compositions and methods for inhibiting expression of the PCSK9 gene
#40 | 2013-07-18Compositions and methods for inhibiting expression of factor VII gene
#41 | 2013-02-07Lipid formulated dsRNA targeting the PCSK9 gene
#42 | 2012-09-27Methods for increasing efficacy of lipid formulated siRNA
#43 | 2012-08-16Compositions and methods for inhibiting expression of factor VII gene
#44 | 2012-02-23Lipid containing formulations
#45 | 2012-01-19Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene
#46 | 2011-09-22Compositions and methods for inhibiting expression of the PCSK9 gene
#47 | 2011-04-28SCREENING METHOD FOR SELECTED AMINO LIPID-CONTAINING COMPOSITIONS
#48 | 2011-02-24LIVER SCREENING METHOD
#49 | 2011-01-20Lipid formulated dsRNA targeting the PCSK9 gene
#50 | 2010-11-18RNAi MODULATION OF HIF-1 AND THERAPUTIC USES THEREOF
#51 | 2010-10-21LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES
#52 | 2010-01-14Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene
#53 | 2010-01-07Compositions and methods for mediating RNAi in vivo
#54 | 2009-11-19Compositions and methods for delivering RNAI using lipoproteins
#55 | 2009-01-22Lipid containing formulations
#56 | 2008-05-15Compositions and methods for inhibiting expression of the PCSK9 gene
#57 | 2007-07-05RNAi modulation of HIF-1 and therapeutic uses thereof
80086 ⎘